A single-residue change in the HIV-1 V3 loop associated with maraviroc resistance impairs CCR5 binding affinity while increasing replicative capacity
Maraviroc (MVC) is an allosteric CCR5 inhibitor used against HIV-1 infection.
Maraviroc (MVC) is an allosteric CCR5 inhibitor used against HIV-1 infection.